β-Adrenergic stimulation induces interleukin-18 expression via β2-AR, PI3K, Akt, IKK, and NF-κB

Biochemical and Biophysical Research Communications

Volumn 319, Issue 2, 2004, Pages 304-311

  Chandrasekar, Bysani ^a   Marelli Berg, Federica M ^b   Tone, Masahide ^c   Bysani, Sailaja ^a   Prabhu, Sumanth D ^d   Murray, David R ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Adrenergic stimulation; Heart failure; Inflammation; Interleukins; Isoproterenol; NF B; Proinflammatory cytokines; Signal transduction

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 18; PHOSPHATIDYLINOSITOL 3 KINASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BETA ADRENERGIC STIMULATION; CONTROLLED STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADRENERGIC BETA-AGONISTS; ANIMALS; CELLS, CULTURED; GENE EXPRESSION REGULATION; I-KAPPA B KINASE; INTERLEUKIN-18; ISOPROTERENOL; MALE; MICE; MICE, INBRED C57BL; MYOCARDIUM; NF-KAPPA B; PROMOTER REGIONS (GENETICS); PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, ADRENERGIC, BETA-2;

EID: 2642562761     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.04.185     Document Type: Article

References (16)

1. Bristow M.R. Beta-adrenergic receptor blockade in chronic heart failure. Circulation. 101:2000;558-569
2. Mann D.L. Stress activated cytokines and the heart. Cytokine Growth Factor Rev. 7:1996;341-354
3. Mann D.L. Basic mechanisms of disease progression in the failing heart: the role of excessive adrenergic drive. Prog. Cardiovasc. Dis. 41:1998;1-8
4. Murray D.R., Prabhu S.D., Chandrasekar B. Chronic beta-adrenergic stimulation induces myocardial proinflammatory cytokine expression. Circulation. 101:2000;2338-2341
5. Seta Y., Kanda T., Tanaka T., Arai M., Sekiguchi K., Yokoyama T., Kurimoto M., Tamura J., Kurabayashi M. Interleukin-18 in patients with congestive heart failure: induction of atrial natriuretic peptide gene expression. Res. Commun. Mol. Pathol. Pharmacol. 108:2000;87-95
6. Gracie J.A., Robertson S.E., McInnes I.B. Interleukin-18. J. Leukoc. Biol. 73:2003;213-224
7. Yamaoka-Tojo M., Tojo T., Inomata T., Machida Y., Osada K., Izumi T. Circulating levels of interleukin 18 reflect etiologies of heart failure: Th1/Th2 cytokine imbalance exaggerates the pathophysiology of advanced heart failure. J. Card. Fail. 8:2002;21-27
8. Woldbaek P.R., Tonnessen T., Henriksen U.L., Florholmen G., Lunde P.K., Lyberg T., Christensen G. Increased cardiac IL-18 mRNA, pro-IL-18 and plasma IL-18 after myocardial infarction in the mouse; a potential role in cardiac dysfunction. Cardiovasc. Res. 59:2003;122-131
9. 2 induce IL-18 and IL-18Rβ expression in cardiomyocytes via NF-κB activation. Biochem. Biophys. Res. Commun. 303:2003;1152-1158
10. Chandrasekar B., Melby P.C., Sarau H.M., Raveendran M., Perla R.P., Marelli-Berg F.M., Dulin N.O., Singh I.S. Chemokine-cytokine cross-talk. The ELR+ CXC chemokine LIX (CXCL5) amplifies a proinflammatory cytokine response via a phosphatidylinositol 3-kinase-NF-κB pathway. J. Biol. Chem. 278:2003;4675-4686
11. Tone M., Thompson S.A., Tone Y., Fairchild P.J., Waldmann H. Regulation of IL-18 (IFN-gamma-inducing factor) gene expression. J. Immunol. 159:1997;6156-6163
12. Prabhu S.D., Chandrasekar B., Murray D.R., Freeman G.L. β-Adrenergic blockade in developing heart failure: effects on myocardial inflammatory cytokines, nitric oxide, and remodeling. Circulation. 101:2000;2103-2109
13. Xiao R.P. Beta-adrenergic signaling in the heart: dual coupling of the beta2-adrenergic receptor to G(s) and G(i) proteins. Sci. STKE. 2001:2001;RE15
14. ′ -kinase Circ. Res. 87:2000;1172-1179
15. Rameh L.E., Cantley L.C. The role of phosphoinositide 3-kinase lipid products in cell function. J. Biol. Chem. 274:1999;8347-8350
16. Oudit G.Y., Crackower M.A., Eriksson U., Sarao R., Kozieradzki I., Sasaki T., Irie-Sasaki J., Gidrewicz D., Rybin V.O., Wada T., Steinberg S.F., Backx P.H., Penninger J.M. Phosphoinositide 3-kinase gamma-deficient mice are protected from isoproterenol-induced heart failure. Circulation. 108:2003;2147-2152